RJR-2403: A nicotinic agonist with cns selectivity I. In vitro characterization

Journal of Pharmacology and Experimental Therapeutics

Volumn 279, Issue 3, 1996, Pages 1413-1421

  Bencherif, M ^a,b   Lovette, M E ^a   Fowler, K W ^a   Arrington, S ^a   Reeves, L ^a   Caldwell, W S ^a   Lippiello, P M ^a  

^a Pharmacology Division   (United States)

^b R J REYNOLDS TOBACCO COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR; MUSCARINIC RECEPTOR; N METHYL 4 (3 PYRIDINYL) 3 BUTENAMINE; NICOTINE; NICOTINIC RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHOLINERGIC SYSTEM; DEGENERATIVE DISEASE; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOSE RESPONSE; DRUG POTENCY; DRUG RECEPTOR BINDING; FEMALE; GUINEA PIG; ILEUM; INTESTINE CONTRACTION; LIGAND BINDING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SYNAPTOSOME; THALAMUS;

ANIMALS; BRAIN; CELL LINE; FEMALE; HUMANS; MICE; NICOTINE; NICOTINIC AGONISTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0030426707     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. ACHESON, R. M., FERRIS, M. J. AND SINCLAIR, N. M.: Transformations involving the pyrrolidine ring of nicotine. J. Chem. Soc. 2: 579-585, 1980.
2. ALKONDON, M. AND ALBUQUERQUE, E. X.: Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther. 265: 1455-1473, 1993.
3. ALKONDON, M., REINHARDT, S., LOBRON, C., HERMSEN, B., MAELICKE, A. AND ALBUQUERQUE, E. X.: Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. II. The rundown and inward rectification of agonist-elicited whole-cell currents and identification of receptors subunits by in situ hybridization. J. Pharmacol. Exp. Ther. 271: 494-506, 1994.
4. ARNERIC, S. P., SULLIVAN, J. P., BRIGGS, C. A., DONNELLY-ROBERTS, D., ANDERSON, D. J., RASZKIEWICZ, J. L., HUGHES, M. L., CADMAN, E. D., ADAMS, GARVEY, D. S., WASICAK, J. T. AND WILLIAMS, M.: (S)-3-Methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT-418*): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization. J. Pharmacol. Exp. Ther. 270: 310-318, 1994.
5. ARNERIC, S. P., SULLIVAN, J. P. AND WILLIAMS, M.: Neuronal nicotinic acetylcholine receptors: Novel targets for CNS therapeutics. pp. 1-16, In Psychopharmacology: The Fourth Generation of Progress, ed. by F. E. Bloom and D. J. Kupfer, Raven Press, New York, 1995.
6. BENCHERIF, M. AND LUKAS, R. J.: Differential regulation of nicotinic acetylcholine receptor expression by human TE671/RD cells following second messenger modulation and sodium butyrate treatments. Mol. Cell. Neurosci. 2: 52-65, 1991a.
7. BENCHERIF, M. AND LUKAS, R. J.: Ligand binding and functional characterization of muscarinic acetylcholine receptors on the TE671/RD cells. J. Pharmacol. Exp. Ther. 257: 946-953, 1991b.
8. BENCHERIF, M. AND LUKAS, R. J.: Cytochalasin modulation of nicotinic cholinergic receptor expression and muscarinic receptor function in human TE671/RD cells: A possible functional role of the cytoskeleton. J. Neurochem. 61: 852-864, 1993.
9. BENCHERIF, M., LOVETTE, M. E., ARRINGTON, S., CALDWELL, W. S., FOWLER, K., REEVES, L. K. AND LIPPIELLO, P. M.: RJR-2403: A nicotine analog with CNS selectivity - in vitro characterization (Abstract). Soc. Neurosc. 21:, 1995.
10. BOULTER, J., CONNOLLY, J., DENERIS, E. S., GOLDMAN, D., HEINEMANN, S. AND PATRICK, J.: Functional expression of two neuronal nicotinic acetylcholine receptors from cDNA clones identifies a gene family. Proc. Natl. Acad. Sci. U.S.A. 84: 7763-7767, 1987.
11. 3H]-dopamine release. Br. J. Pharmacol. 117: 595-606, 1996.
12. COUTURIER, S., BERTRAND, D., MATTER, J.-M., HERNANDEZ, M.-C., BERTRAND, S., MILNAR, N., VALERA, S., BARKAS, T AND BALLIVET, M.: A neuronal nicotinic acetylcholine receptor subunit (a7) is developmentally regulated and forms a homo-oligomeric channel blocked by a-BTX. Neuron 5: 847-856, 1990.
13. 125I-a-bungarotoxin receptor subtypes. Mol. Pharmacol. 47: 164-171, 1995.
14. DENERIS, E. S., CONNOLLY, J. G., BOULTER, J., WADA, E., WADA, K., SWANSON, L. W., PATRICK, J. AND HEINEMANN, S.: Primary structure and expression of beta2: A novel subunit of neuronal nicotinic acetylcholine receptors. Neuron 1: 45-54, 1988.
15. DENERIS, E. S., CONNOLLY, ROGERS, S. W. AND DUVOISIN, R.: Pharmacological and functional diversity of neuronal nicotinic acetylcholine receptors. Trends Pharmacol. Sci. 12: 34-40, 1991.
16. ELGOYHEN, A. B., JOHNSON, D., BOULTER, J., VETTER, D. AND HEINEMANN, S. F.: Alpha-9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79: 705-715, 1994.
17. FLORES, C. M., ROGERS, S. W., PABREZA, L. A., WOLFE, B. AND KELLAR, K. J.: A subtype of nicotinic cholinergic receptor is composed of α4 and β2 subunits and is upregulated by chronic nicotine treatment. Mol. Pharmacol. 45: 212-220, 1994.
18. GARVEY, D. S., WASICAK, J., DECKER, M. W., BRIONI, J. D., SULLIVAN, J. P., CARRERA, G. M., HOLLADAY, M. H., ARNERIC, S. P. AND WILLIAMS, M.: Novel isoxazoles which interact with brain cholinergic channel receptors have intrinsic cognitive enhancing and anxiolytic activities. J. Med. Chem. 37: 1055-1059, 1994.
19. GEBBER, G. L.: Neurogenic basis for the rise in blood pressure evoked by nicotine in the cat. J. Pharmacol. Exp. Ther. 166: 255-269, 1969.
20. GERZANICH, V., ANAND, R. AND LINDSTROM, J.: Homomers of α8 and α7 subunits of nicotinic receptors exhibit similar channel but contrasting binding site properties. Mol. Pharmacol. 45: 212-220, 1994.
21. GREENE, L. A. AND TISCHLER, A. S.: Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Pro. Natl. Acad. Sci. U.S.A. 73: 2424-2428, 1976.
22. GOLDMAN, D., DENERIS, E., LUYTEN, W., KOCHHAR, A., PATRICK, J. AND HEINEMANN, S.: Members of a nicotinic acetylcholine receptor gene family are expressed in different regions of the mammalian central nervous system. Cell 48: 965-973, 1987.
23. 3H]-dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59: 848-856, 1992.
24. HANSCH, C., STEWARD, A. R., ANDERSON, S. M. AND BENTLEY, D.: The parabolic dependence of drug action upon lipophilic character as revealed by a study of hypnotics. J. Med. Chem. 11: 1-11, 1968.
25. JONES, G. M., SAHAKIAN, B. J., LEVY, R., WARBURTON, D. M. AND GRAY, J. A.: Effects of acute subcutaneous nicotine on attention, information processing, and short-term memory in Alzheimer's disease. Psychopharmacology 108: 485-494, 1992.
26. LIPPIELLO, P. M. AND FERNANDES, K. G.: The binding of L-[3H] nicotine to a single class of high affinity sites in rat brain membranes. Mol. Pharmacol. 29: 448-454, 1986.
27. LIPPIELLO, P. M., GRAY, J. A., PETERS, S., GRIGORYAN, G., HODGES, H., SUMMERS, K., GIACOBINI, E. AND COLLINS, A. C.: Metanicotine: A nicotinic agonist with CNS selectivity - in vivo characterization (Abstract). Soc. Neurosci. 21: 605, 1995.
28. LIPPIELLO, P. M., CALDWELL, W. S., MARKS, M. J. AND COLLINS, A. C.: Development of nicotinic agonists for the treatment of Alzheimer's disease. In Alzheimer's Disease, Therapeutic Strategies, ed. by E. Giacobini and R. Becker, pp. 186-190, Birkhauser Boston, Inc., 1994.
29. 3H]nicotine binding to putative high affinity receptor sites in rat brain. Mol. Pharmacol. 31: 392-400, 1987.
30. LUETJE, C. W. AND PATRICK, J.: Both a- and b-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 55: 837-845, 1991.
31. LUKAS, R. J.: Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma. J. Pharmacol. Exp. Ther. 251: 175-182, 1989.
32. LUKAS, R. J., NORMAN, S. A. AND LUCERO, L.: Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol. Cell. Neurosci. 4: 1-12, 1993.
33. LUTHER, M. A., SCHOEPFER, R., WHITING, P., CASEY, B., BLATT, Y., MONTAL, M. S., MONTAL, M. AND LINDSTROM, J.: A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671. J. Neurosc. 9: 1082-1096, 1989.
34. MARKS, M. J., FARNHAM, D. A., GRADY, S. R. AND COLLINS, A. C.: Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 264: 542-552, 1993.
35. MCALLISTER, R. M., ISSACS, H., RONGEY, R., PEER, M., AU, W., SOUKUP, S. W. AND GARDNER, M. B.: Establishment of a human medulloblastoma cell line TE671. J. Neurosci. 9: 1082-1096, 1977.
36. MCCONVILLE, B. J., SANBERG, P. R., FOGELSON, H. M., KING, J., CIRINO, P., PARKER, K. W. AND NORMAN, A. B.: The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder. Biol. Psychiatry 31: 832-840, 1992.
37. MCGEHEE, D. S., HEATH, M. J. S., GELBER, S., DEVAY, P. AND ROLE, L. W.: Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science (Wash. DC) 269: 1692-1696, 1995.
38. MEYER, E., DEFIEBRE, C. M., HUNTER, M., SIMPKINS, C. E., FRAUWORTH, N. AND DEFIEBRE, N. C.: Effects of anabaseine-related analogs on rat brain nicotinic receptor binding and on avoidance behaviors. Drug Dev. Res. 31: 127-134, 1994.
39. NEF, P., ONEYSER, C., ALLIOD, C., COUTURIER, S. AND BALLIVET, M.: Genes expressed in the brain define three distinct neuronal nicotinic acetylcholine receptors. Embo. J. 7: 595-601, 1988.
40. 3H]Cytisine binding to nicotinic cholinergic receptors in brain. Mol. Pharmacol. 41: 9-12, 1991.
41. PAPKE, R. L.: The kinetic properties of neuronal nicotinic receptors: Genetic basis of functional diversity. Prog. Neurobiol. 41: 509-531, 1993.
42. PAPKE, R. L. AND HEINEMANN, S. F.: Partial agonist properties of cytisine on neuronal nicotinic receptors containing the b2 subunits. Mol. Pharmacol. 45: 142-149, 1994.
43. PENG, X., GERZANICH, V., ANAND, R., WHITING, P. J. AND LINDSTROM, J.: Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol. Pharmacol. 46: 523-530, 1994.
44. PULLAN, R. D., RHODES, J., GANESH, S., MANI, V., MORRIS, J. S., WILLIAMS, G. T., NEWCOMBE, R. G., RUSSELL, M. A. H., FEYERABEND, C., THOMAS, G. A. O. AND SAWE, U.: Transdermal nicotine for ulcerative colitis. New Engl. J. Med. 330: 811-815, 1994.
45. RAPIER, C., LUNT, G. G. AND WONNACOTT, S.: Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: Concentration dependence and repetitive stimulation. J. Neurochem. 50: 1123-1130, 1988.
46. ROGERS, S. W., MANDELZYS, A., DENERIS, E. S., COOPER, E. AND HEINEMANN, S.: The expression of nicotinic acetylcholine receptor by PC12 cells treated with NGF. J. Neurosci. 12: 4611-4623, 1992.
47. SAHAKIAN, B., JONES, G., LEVY, R., GRAY, J. AND WARBURTON, D.: The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of the Alzheimer type. Br. J. Psychiatry 154: 797-800, 1989.
48. SARGENT, P. B.: The diversity of neuronal nicotinic acetylcholine receptors. Ann. Rev. Neurosc. 16: 403-443, 1993.
49. SEGUELA, P., WADICHE, J., DINELEY-MILLER, K., DANI, J. A. AND PATRICK, J. W.: Molecular cloning, functional properties and distribution of rat brain alpha7: A nicotinic cation channel highly permeable to calcium. J. Neurosci. 13: 596-604, 1993.
50. SILVER, A. A., SHYTLE, R. D., PHILIPP, M. K. AND SANBERG, P. R.: Transdermal nicotine in Tourette's syndrome. In International Symposium on Nicotine: The Effects of nicotine on biological systems. II. Advances in Pharmacological Sciences, ed. by P. B. S. Clarke, M. Quik, F. Adlkofer and K. Thurau, Birkhauser Verlag, Basel, pp. 293-299, 1994.
51. SMITH, C. P., BROUGHAM, L. R. AND VARGAS, H. M.: Linopirdine (DuP 996) selectively enhances acetylcholine release induced by high potassium, but not electrical stimulation, in rat brain slices and guinea pig ileum. Drug Dev. Res. 29: 262-270, 1993.
52. SMITH, P. K., KROHN, R. I., HERMANSON, G. T., MALLIA, A. K., GARTNER, F. H., PROVENZANO, M. D., FUJIMOTO, E. K., GOEKE, N. M., OLSON, B. J. AND KLENK, D. C.: Measurement of protein using bicinchoninic acid. Anal. Biochem. 150: 76-85, 1985.
53. SULLIVAN, J. P. AND BANNON, A. W.: Epibatidine: Pharmacological properties of a novel nicotinic acetylcholine receptor agonist and analgesic agent. CNS Drug Reviews 2: 21-39, 1996.
54. SUMMERS, K. L., LIPPIELLO, P., VERHULST, S. AND GIACOBINI, E.: 5-Fluoronicotine, noranhydroecgonine, and pyridyl-methylpyrrolidine release acetylcholine and biogenic amines in rat cortex in vivo. Neurochem. Res. 20: 1089-1094, 1995.
55. TAYLOR, P.: Ganglionic stimulating and blocking agents. In The Pharmacological Basis of Therapeutics, ed. by L. S. Goodman and A. Gilman, pp. 214-219, McMillan, New York, 1980.
56. THOMAS, G. A. O. AND RHODES, J.: Relationship between smoking, nicotine and ulcerative colitis. In International Symposium on Nicotine: The effects of Nicotine on Biological Systems. II. Advances in Pharmacological Sciences, ed. by P. B. S. Clarke, M. Quik, F. Adlkofer and K. Thurau, pp. 287-305, Birkhauser Verlag, Basel, 1994.
57. WHITING, P. J., SCHOEPFER, R., LINDSTROM, M. J. AND PRIESTLEY, T.: Structural and pharmacological characterization of the major brain nicotinic acetylcholine receptor subtype stably expressed in mouse fibroblasts. Mol. Pharmacol. 40: 463-472, 1991.
58. WONNACOTT, S., DRASDO, A., SANDERSON, E. AND ROWELL, P.: Presynaptic nicotinic receptors and the modulation of transmitter release. In The Biology of Nicotine Dependence, ed. by G. Bock and J. Marsh, pp. 87-101, John Wiley & Sons, Chichester, 1990.
59. YATES, S. L., BENCHERIF, M., FLUHLER, E. AND LIPPIELLO, P. M.: Up-regulation of nicotinic acetylcholine receptors occurs following chronic exposure of rat to mainstream cigarette smoke or a4b2 receptors to nicotine. Biochem. Pharmacol. 50: 2001-2008, 1995.